Osteopontin is not required for the development of Th1 responses and viral immunity

被引:29
作者
Abel, B
Freigang, S
Bachmann, MF
Boschert, U
Kopt, M
机构
[1] Swiss Fed Inst Technol, Mol Biomed, CH-8952 Zurich, Schlieren, Switzerland
[2] Cytos Biotechnol AG, Zurich, Switzerland
[3] Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland
[4] Serono Pharmaceut Res Inst, Dept Immunol, Geneva, Switzerland
关键词
D O I
10.4049/jimmunol.175.9.6006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteopontin (OPN) has been defined as a key cytokine promoting the release of IL-12 and hence inducing the development of protective cell-mediated immunity to viruses and intracellular pathogens. To further characterize the role of OPN in antiviral immunity, OPN-deficient (OPN-/-) mice were analyzed after infection with influenza virus and vaccinia virus. Surprisingly, we found that viral clearance, lung inflammation, and recruitment of effector T cells to the lung were unaffected in OPN-/- mice after influenza infection. Furthermore, effector status of T cells was normal as demonstrated by normal IFN-gamma production and CTL lytic activity. Moreover, activation and Th1 differentiation of naive TCR transgenic CD4(+) T cells by dendritic cells and cognate Ag was normal in the absence of OPN in vitro. Contrary to a previous report, we found that OPN-/- mice mounted a normal immune response to Listeria monocytogenes. In conclusion, OPN is dispensable for antiviral immune responses against influenza virus and vaccinia virus.
引用
收藏
页码:6006 / 6013
页数:8
相关论文
共 47 条
  • [11] High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation
    Chiocchetti, A
    Indelicato, M
    Bensi, T
    Mesturini, R
    Giordano, M
    Sametti, S
    Castelli, L
    Bottarel, F
    Mazzarino, MC
    Garbarini, L
    Giacopelli, F
    Valesini, G
    Santoro, C
    Dianzani, I
    Ramenghi, U
    Dianzani, U
    [J]. BLOOD, 2004, 103 (04) : 1376 - 1382
  • [12] Post-translationally modified residues of native human osteopontin are located in clusters: identification of 36 phosphorylation and five O-glycosylation sites and their biological implications
    Christensen, B
    Nielsen, MS
    Haselmann, KF
    Petersen, TE
    Sorensen, ES
    [J]. BIOCHEMICAL JOURNAL, 2005, 390 : 285 - 292
  • [13] Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus
    D'Alfonso, S
    Barizzone, N
    Giordano, M
    Chiocchetti, A
    Magnani, C
    Castelli, L
    Indelicato, M
    Giacopelli, F
    Marchini, M
    Scorza, R
    Danieli, MG
    Cappelli, M
    Migliaresi, S
    Bighardo, B
    Sabbadini, MG
    Baldissera, E
    Galeazzi, A
    Sebastiani, GD
    Minisola, G
    Ravazzolo, R
    Dianzani, U
    Momigliano-Richiardi, P
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 539 - 547
  • [14] Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
    Denhardt, DT
    Noda, M
    O'Regan, AW
    Pavlin, D
    Berman, JS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (09) : 1055 - 1061
  • [15] A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes
    Geginat, G
    Schenk, S
    Skoberne, M
    Goebel, W
    Hof, H
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (03) : 1877 - 1884
  • [16] Mice with osteopontin deletion remain predisposed to collagen-induced arthritis
    Ishii, T
    Ohshima, S
    Ishida, T
    Kawase, I
    Mima, T
    Tabunoki, Y
    Kobayashi, H
    Maeda, M
    Uede, T
    Liaw, L
    Kinoshita, N
    Saeki, Y
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (02): : 669 - 671
  • [17] Osteopontin as a positive regulator in the osteoclastogenesis of arthritis
    Ishii, T
    Ohshima, S
    Ishida, T
    Mima, T
    Tabunoki, Y
    Kobayashi, H
    Maeda, M
    Uede, T
    Liaw, L
    Kinoshita, N
    Kawase, I
    Saeki, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 316 (03) : 809 - 815
  • [18] Cutting edge: Attenuated experimental autoimmune encephalomyelitis in Eta-1/osteopontin-deficient mice
    Jansson, M
    Panoutsakopoulou, V
    Baker, J
    Klein, L
    Cantor, H
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (05) : 2096 - 2099
  • [19] Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells
    Koguchi, Y
    Kawakami, K
    Kon, S
    Segawa, T
    Maeda, M
    Uede, T
    Saito, A
    [J]. INFECTION AND IMMUNITY, 2002, 70 (03) : 1042 - 1048
  • [20] Endotoxin contamination contributes to the in vitro cytokine-inducing activity of osteopontin preparations
    Konno, S
    Hoshi, T
    Taira, T
    Plunkett, B
    Huang, SK
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (05) : 277 - 282